Search

Search Constraints

You searched for: Journal Prostate

Search Results

1. 177Lu‐PSMA radioligand therapy effectiveness in metastatic castration‐resistant prostate cancer: An updated systematic review and meta‐analysis. Issue 7 (14th March 2022)

2. 18F‐DCFPyL positron emission tomography/magnetic resonance imaging‐guided ultrasound fusion biopsy is an identical pathway in prostate cancer diagnosis. Issue 2 (25th October 2022)

3. 18F‐labeled 1, 2, 3‐triazole‐linked Glu‐urea‐Lys‐based PSMA ligands have good pharmacokinetic properties for positron emission tomography imaging of prostate cancer. Issue 16 (22nd September 2020)

4. 18F‐RB390: Innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET). Issue 4 (30th October 2014)

10. 68Ga‐PSMA‐11 PET‐CT study in prostate cancer patients with biochemical recurrence and non‐contributive 18F‐Choline PET‐CT: Impact on therapeutic decision‐making and biomarker changes. Issue 5 (14th December 2018)